{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:21:30Z","timestamp":1794576090759,"version":"4.9.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gynecological diseases significantly impact the reproductive health in women of childbearing age (WCBA). However, there is currently a lack of analysis on the specific burden and forecast of common gynecological diseases for this population. The aim of this study was to provide new details for gynecological disorders in WCBA from 1990 to 2021 worldwide based on the Global Burden of Disease (GBD) data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Employing data from the GBD 2021, we analyzed the disability-adjusted life years (DALYs), death, incidence, and prevalence for thirteen types of gynecological disorders by socioeconomic development index (SDI), age, year, and location in WCBA. Age-standardized rates were used to compare the burdens across various time periods and locations. Temporal trends were assessed using Joinpoint regression analysis from 1990 to 2021, the Bayesian age-period-cohort (BAPC) model projected the disease burden through 2031, and the Nordpred model conducted a sensitivity analysis of the prediction results, which validated the findings' reliability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1990 to 2021, the age\u2013standardized DALYs rate (ASDR) and mortality rate (ASMR) of combined gynecological diseases (CGDs) increased by AAPC of 0.28% (95% CI 0.19 to 0.36) and 0.53% (95% CI 0.25 to 0.82) among WCBA. Furthermore, the projections showed a declining trend in the next decade, with ASDR and ASMR dropping by 11.06% and 25.23%, respectively. Notably, HIV\/AIDS, polycystic ovary syndrome (PCOS), infertility, premenstrual syndrome (PMS) were the key drivers behind the increased ASDR of CGDs. In 2021, HIV\/AIDS (16.38 million), PMS (7.43 million), and cervical cancer (4.18 million) topped the list for the absolute number of DALYs globally among WCBA. CGDs burdens were negatively correlated with and SDI. Women aged 15\u201324\u00a0years showed the most significant rise in CGDs burdens, highlighting its increasingly affecting younger women. The DALYs and death of malignant gynecological tumors are most significant in women aged 40\u201349\u00a0years, the incidence of PCOS predominantly occurs in 15\u201319\u00a0years, and infertility prevalence peaks at 30\u201339\u00a0years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The global CGDs burden has increased over the last 32\u00a0years, and higher in lower SDI countries. Immediate and effective interventions should be taken to target different types of gynecological disorders, age groups, and countries with high gynecological disease burdens. These findings would provide targeted insights for public health policies and interventions enhancing reproductive health in women of childbearing age.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12978-025-02013-1","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T02:21:46Z","timestamp":1745202106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Rising global burden of common gynecological diseases in women of childbearing age from 1990 to 2021: an update from the Global Burden of Disease Study 2021"],"prefix":"10.1186","volume":"22","author":[{"given":"Yidan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuixiu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanshuo","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoneng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"15","key":"2013_CR1","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/jama.2023.5076","volume":"329","author":"AC Eke","year":"2023","unstructured":"Eke AC, Lockman S, Mofenson LM. Antiretroviral treatment of HIV\/AIDS during pregnancy. JAMA. 2023;329(15):1308\u20139.","journal-title":"JAMA"},{"issue":"5","key":"2013_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.fertnstert.2023.03.018","volume":"119","author":"P Vercellini","year":"2023","unstructured":"Vercellini P, Vigan\u00f2 P, Bandini V, Buggio L, Berlanda N, Somigliana E. Association of endometriosis and adenomyosis with pregnancy and infertility. Fertil Steril. 2023;119(5):727\u201340.","journal-title":"Fertil Steril"},{"issue":"3","key":"2013_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ajog.2020.10.019","volume":"224","author":"J Ravel","year":"2021","unstructured":"Ravel J, Moreno I, Sim\u00f3n C. Bacterial vaginosis and its association with infertility, endometritis, and pelvic inflammatory disease. Am J Obstet Gynecol. 2021;224(3):251\u20137.","journal-title":"Am J Obstet Gynecol"},{"key":"2013_CR4","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1093\/cid\/ciac030","volume":"74","author":"PJ Kissinger","year":"2022","unstructured":"Kissinger PJ, Gaydos CA, Se\u00f1a AC, Scott McClelland R, Soper D, Secor WE, et al. Diagnosis and management of trichomonas vaginalis: summary of evidence reviewed for the 2021 centers for disease control and prevention sexually transmitted infections treatment guidelines. Clin Infect Dis. 2022;74:S152-s61.","journal-title":"Clin Infect Dis"},{"key":"2013_CR5","unstructured":"WHO. Protect the promise: 2022 progress report on the every woman every child global strategy for women\u2019s, children\u2019s and adolescents\u2019 health (2016\u20132030). 2022 [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240060104."},{"key":"2013_CR6","unstructured":"WHO. 6 Priorities for women and health 2021 [Available from: https:\/\/www.who.int\/news-room\/spotlight\/6-priorities-for-women-and-health."},{"key":"2013_CR7","unstructured":"WHO. Targets of sustainable development goal 3. 2015 [Available from: https:\/\/www.who.int\/europe\/about-us\/our-work\/sustainable-development-goals\/targets-of-sustainable-development-goal-3."},{"key":"2013_CR8","doi-asserted-by":"publisher","first-page":"102713","DOI":"10.1016\/j.eclinm.2024.102713","volume":"74","author":"P Sun","year":"2024","unstructured":"Sun P, Yu C, Yin L, Chen Y, Sun Z, Zhang T, et al. Global, regional, and national burden of female cancers in women of child-bearing age, 1990\u20132021: analysis of data from the global burden of disease study 2021. EClinicalMedicine. 2024;74:102713.","journal-title":"EClinicalMedicine"},{"issue":"8","key":"2013_CR9","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/humrep\/deac091","volume":"37","author":"S Safiri","year":"2022","unstructured":"Safiri S, Noori M, Nejadghaderi SA, Karamzad N, Carson-Chahhoud K, Sullman MJM, et al. Prevalence, incidence and years lived with disability due to polycystic ovary syndrome in 204 countries and territories, 1990\u20132019. Hum Reprod. 2022;37(8):1919\u201331.","journal-title":"Hum Reprod"},{"issue":"6","key":"2013_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/humrep\/deae081","volume":"39","author":"X Liu","year":"2024","unstructured":"Liu X, Li R, Wang S, Zhang J. Global, regional, and national burden of premenstrual syndrome, 1990\u20132019: an analysis based on the global burden of disease study 2019. Hum Reprod. 2024;39(6):1303\u201315.","journal-title":"Hum Reprod"},{"key":"2013_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2024.06.022","author":"Y Cao","year":"2024","unstructured":"Cao Y, Guo Y, Long Z, Wu Y, Pei B, Ye J, et al. The global burden of gynecological diseases from 1990 to 2019. Am J Prev Med. 2024. https:\/\/doi.org\/10.1016\/j.amepre.2024.06.022.","journal-title":"Am J Prev Med"},{"issue":"7","key":"2013_CR12","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1136\/ijgc-2020-001652","volume":"31","author":"W Small Jr","year":"2021","unstructured":"Small W Jr, Peltecu G, Puiu A, Corha A, Coc\u00eer\u1e6d\u0103 E, Cig\u0103ran RG, et al. Cervical cancer in Eastern Europe: review and proceedings from the cervical cancer research conference. Int J Gynecol Cancer. 2021;31(7):1061\u20137.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2013_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12978-023-01611-1","volume":"20","author":"MR Pradhan","year":"2023","unstructured":"Pradhan MR, Mondal S, Mudi PK. Gynecological morbidity and treatment-seeking among older adult (aged 45\u201359) women in India. Reprod Health. 2023;20(1):64.","journal-title":"Reprod Health"},{"issue":"10440","key":"2013_CR14","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"GF Collaborators","year":"2024","unstructured":"Collaborators GF. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2204\u201356.","journal-title":"Lancet"},{"key":"2013_CR15","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.arr.2024.102382","volume":"99","author":"F Cao","year":"2024","unstructured":"Cao F, Xu Z, Li XX, Fu ZY, Han RY, Zhang JL, et al. Trends and cross-country inequalities in the global burden of osteoarthritis, 1990\u20132019: a population-based study. Ageing Res Rev. 2024;99:102382.","journal-title":"Ageing Res Rev"},{"key":"2013_CR16","doi-asserted-by":"crossref","unstructured":"Collaborators GDaI. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024; 403(10440): 2133-61.","DOI":"10.1016\/S0140-6736(24)00757-8"},{"issue":"10440","key":"2013_CR17","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GRF Collaborators","year":"2024","unstructured":"Collaborators GRF. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: a systematic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):2162\u2013203.","journal-title":"Lancet"},{"issue":"3","key":"2013_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2013_CR19","unstructured":"WHO. Maternal, newborn, child, and adolescent health and aging. 2024 [Available from: https:\/\/platform.who.int\/data\/maternal-newborn-child-adolescent-ageing\/maternal-and-newborn-data\/maternal-and-newborn---demographics."},{"key":"2013_CR20","unstructured":"Network. GBoDC. Global burden of disease study 2021 (GBD 2021) Results. [Available from: https:\/\/vizhub.healthdata.org\/gbd-results\/."},{"key":"2013_CR21","unstructured":"Network. GBoDC. Global burden of disease study 2021 (GBD 2021) socio-demographic index (SDI) 1950\u20132021. [Available from: https:\/\/ghdx.healthdata.org\/record\/global-burden-disease-study-2021-gbd-2021-socio-demographic-index-sdi-1950%E2%80%932021."},{"issue":"10440","key":"2013_CR22","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","author":"GD Collaborators","year":"2024","unstructured":"Collaborators GD. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950\u20132021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the global burden of disease study 2021. Lancet. 2024;403(10440):1989\u20132056.","journal-title":"Lancet"},{"key":"2013_CR23","doi-asserted-by":"publisher","first-page":"e078432","DOI":"10.1136\/bmj-2023-078432","volume":"385","author":"K Yang","year":"2024","unstructured":"Yang K, Yang X, Jin C, Ding S, Liu T, Ma B, et al. Global burden of type 1 diabetes in adults aged 65 years and older, 1990\u20132019: population based study. BMJ. 2024;385:e078432.","journal-title":"BMJ"},{"key":"2013_CR24","unstructured":"Surveillance research program NCI. Joinpoint regression program, version 5.0.2 2023 [Available from: https:\/\/surveillance.cancer.gov\/joinpoint\/."},{"issue":"3","key":"2013_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335\u201351.","journal-title":"Stat Med"},{"issue":"1","key":"2013_CR26","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12874-020-01133-5","volume":"20","author":"M Knoll","year":"2020","unstructured":"Knoll M, Furkel J, Debus J, Abdollahi A, Karch A, Stock C. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med Res Methodol. 2020;20(1):257.","journal-title":"BMC Med Res Methodol"},{"issue":"10258","key":"2013_CR27","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","volume":"396","author":"SE Vollset","year":"2020","unstructured":"Vollset SE, Goren E, Yuan CW, Cao J, Smith AE, Hsiao T, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet. 2020;396(10258):1285\u2013306.","journal-title":"Lancet"},{"issue":"2","key":"2013_CR28","doi-asserted-by":"publisher","first-page":"e1003679","DOI":"10.1371\/journal.pmed.1003679","volume":"19","author":"SS Venkatesh","year":"2022","unstructured":"Venkatesh SS, Ferreira T, Benonisdottir S, Rahmioglu N, Becker CM, Granne I, et al. Obesity and risk of female reproductive conditions: a Mendelian randomisation study. PLoS Med. 2022;19(2):e1003679.","journal-title":"PLoS Med"},{"issue":"1","key":"2013_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13148-023-01584-9","volume":"15","author":"AS Avramenko","year":"2023","unstructured":"Avramenko AS, Flanagan JM. An epigenetic hypothesis for ovarian cancer prevention by oral contraceptive pill use. Clin Epigenetics. 2023;15(1):165.","journal-title":"Clin Epigenetics"},{"issue":"10148","key":"2013_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","volume":"392","author":"J Ghosn","year":"2018","unstructured":"Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. Lancet. 2018;392(10148):685\u201397.","journal-title":"Lancet"},{"key":"2013_CR31","doi-asserted-by":"publisher","first-page":"106295","DOI":"10.1016\/j.ypmed.2020.106295","volume":"144","author":"C Godfrey","year":"2021","unstructured":"Godfrey C, Prainito A, Lapidos-Salaiz I, Barnhart M, Watts DH. Reducing cervical cancer deaths in women living with HIV: PEPFAR and the go further partnership. Prev Med. 2021;144:106295.","journal-title":"Prev Med"},{"issue":"9","key":"2013_CR32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","volume":"10","author":"AE Joham","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, Legro RS, Franks S, Moran LJ, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668\u201380.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"2013_CR33","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/humrep\/dead053","volume":"38","author":"LJ Dobbie","year":"2023","unstructured":"Dobbie LJ, Pittam B, Zhao SS, Alam U, Hydes TJ, Barber TM, et al. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis. Hum Reprod. 2023;38(6):1168\u201382.","journal-title":"Hum Reprod"},{"issue":"7","key":"2013_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/jama.2023.12317","volume":"330","author":"DD Rahn","year":"2023","unstructured":"Rahn DD, Richter HE, Sung VW, Pruszynski JE, Hynan LS. Perioperative vaginal estrogen as adjunct to native tissue vaginal apical prolapse repair: a randomized clinical trial. JAMA. 2023;330(7):615\u201325.","journal-title":"JAMA"},{"issue":"3","key":"2013_CR35","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.1016\/S2352-3018(20)30271-X","volume":"8","author":"J Ambrosioni","year":"2021","unstructured":"Ambrosioni J, Petit E, Liegeon G, Laguno M, Mir\u00f3 JM. Primary HIV-1 infection in users of pre-exposure prophylaxis. Lancet HIV. 2021;8(3):e166-74.","journal-title":"Lancet HIV"},{"key":"2013_CR36","unstructured":"UNAIDS. Global AIDS strategy 2021\u20132026 \u2014 end inequalities. End AIDS. 2021 [Available from: https:\/\/www.unaids.org\/en\/resources\/documents\/2021\/2021-2026-global-AIDS-strategy."},{"issue":"10","key":"2013_CR37","doi-asserted-by":"publisher","first-page":"e25818","DOI":"10.1002\/jia2.25818","volume":"24","author":"K Joshi","year":"2021","unstructured":"Joshi K, Lessler J, Olawore O, Loevinsohn G, Bushey S, Tobian AAR, et al. Declining HIV incidence in sub-Saharan Africa: a systematic review and meta-analysis of empiric data. J Int AIDS Soc. 2021;24(10):e25818.","journal-title":"J Int AIDS Soc"},{"issue":"4","key":"2013_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/humupd\/dmv016","volume":"21","author":"MC Inhorn","year":"2015","unstructured":"Inhorn MC, Patrizio P. Infertility around the globe: new thinking on gender, reproductive technologies and global movements in the 21st century. Hum Reprod Update. 2015;21(4):411\u201326.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"2013_CR39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/humrep\/dead225","volume":"39","author":"O Fitzgerald","year":"2024","unstructured":"Fitzgerald O, Dyer S, Zegers-Hochschild F, Keller E, Adamson GD, Chambers GM. Gender inequality and utilization of ART: an international cross-sectional and longitudinal analysis. Hum Reprod. 2024;39(1):209\u201318.","journal-title":"Hum Reprod"},{"issue":"3","key":"2013_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.rbmo.2021.06.018","volume":"43","author":"BL Oliveira","year":"2021","unstructured":"Oliveira BL, Ataman LM, Rodrigues JK, Birchal TS, Reis FM. Restricted access to assisted reproductive technology and fertility preservation: legal and ethical issues. Reprod Biomed Online. 2021;43(3):571\u20136.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"2013_CR41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1192\/bjp.2021.222","volume":"221","author":"C Gastaldon","year":"2022","unstructured":"Gastaldon C, Solmi M, Correll CU, Barbui C, Schoretsanitis G. Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies. Br J Psychiatry. 2022;221(4):591\u2013602.","journal-title":"Br J Psychiatry"},{"issue":"1","key":"2013_CR42","doi-asserted-by":"publisher","first-page":"101858","DOI":"10.1016\/j.beem.2023.101858","volume":"38","author":"E Cary","year":"2024","unstructured":"Cary E, Simpson P. Premenstrual disorders and PMDD - a review. Best Pract Res Clin Endocrinol Metab. 2024;38(1):101858.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2013_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1037\/rev0000058","volume":"124","author":"J Kiesner","year":"2017","unstructured":"Kiesner J. The menstrual cycle-response and developmental affective-risk model: a multilevel and integrative model of influence. Psychol Rev. 2017;124(2):215\u201344.","journal-title":"Psychol Rev"},{"issue":"21","key":"2013_CR44","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1002\/cncr.33795","volume":"127","author":"S Lin","year":"2021","unstructured":"Lin S, Gao K, Gu S, You L, Qian S, Tang M, et al. Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer. 2021;127(21):4030\u20139.","journal-title":"Cancer"},{"key":"2013_CR45","unstructured":"WHO. Global strategy to accelerate the elimination of cervical cancer as a public health problem. [Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240014107."},{"issue":"10224","key":"2013_CR46","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S0140-6736(20)30068-4","volume":"395","author":"M Brisson","year":"2020","unstructured":"Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575\u201390.","journal-title":"Lancet"}],"container-title":["Reproductive Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-025-02013-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12978-025-02013-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12978-025-02013-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T02:21:54Z","timestamp":1745202114000},"score":1,"resource":{"primary":{"URL":"https:\/\/reproductive-health-journal.biomedcentral.com\/articles\/10.1186\/s12978-025-02013-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2013"],"URL":"https:\/\/doi.org\/10.1186\/s12978-025-02013-1","relation":{},"ISSN":["1742-4755"],"issn-type":[{"value":"1742-4755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data used in this article were sourced from the publicly available GBD 2021 database, therefore, did not require institutional review board approval, ethics clearance or consent from study subjects. This study is exempted from IRB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}